| 01/01/2016 |
Hinman’s Urology Surgery Atlas, 5th Edition 2016 |
|
Book Chapters |
| 01/01/2020 |
Tumor downstagingin muscle invasive bladder cancer with neoadjuvant systemic therapy-does it lead to prolonged survival? |
Translational Andrology and Urology |
Invited Reviews |
| 01/01/2021 |
Photoswitchable Machine-Engineered Plasmonic Nanosytem with High Optical Response for Ultrasensitive Detection of microRNAs and Proteins Adaptively |
Anal Chem |
Journal Articles |
| 01/01/2020 |
A novel, safe, fast and efficient treatment for Her2-positive and negative bladder cancer utilizing an EGF-anthrax toxin chimera |
|
Journal Articles |
| 01/01/2020 |
A novel liquid biopsy-based approach for highly specific cancer diagnostics mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses |
|
Journal Articles |
| 01/01/2020 |
Bottom-Up Fabrication of Plasmonic Nanoantenna-Based High-throughput Multiplexing Biosensors for Ultrasensitive Detection of microRNAs Directly from Cancer Patients' Plasma |
|
Journal Articles |
| 01/01/2020 |
Micropapillary urothelial carcinoma of the bladder displays immunophenotypic features of luminal and p53-like subtypes and is not a variant of adenocarcinoma. |
Uro. Onco |
Journal Articles |
| 01/11/2019 |
Antitumor activity and mechanistic characterization of APE1/Ref-1 inhibitors in bladder cancer |
|
Journal Articles |
| 01/04/2017 |
TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract |
Oncology |
Journal Articles |
| 01/01/2014 |
The Expression Patterns of p53 and p16 and an Analysis of a Possible Role of HPV in Primary Adenocarcinoma of the Urinary Bladder |
|
Journal Articles |
| 01/01/2014 |
Surface modified nanoparticles enhance transurothelial penetration anddelivery of survivin siRNA in treating bladder cancer |
Molecular Cancer Therapeutics |
Journal Articles |
| 01/01/2013 |
Nanoparticle encapsulation of belinostat in the treatment of bladder cancer in an animal model |
Nanomedicine |
Journal Articles |
| 01/01/2011 |
Uptake of Surface Modified Poly(Lactide-Co-Glycolide) Nanoparticles in Bladder Cancer Cells and in Human Ureter and Mouse Bladder |
Urology |
Journal Articles |
| 01/01/2011 |
Nanoparticle delivery of the histone deacetylase inhibitor PXD101 facilitates bladder cancer cell uptake and cytotoxicity |
|
Journal Articles |
| 01/01/2011 |
Surface modifications of poly(lactide-co-glycolide) nanoparticles can increase its uptake by bladder cancer cells. Journal of Urology 2011, 185 (4), 424. |
|
Journal Articles |
| 01/01/2011 |
Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C. BJU Int. 2011; 107(7): 1154-61. |
|
Journal Articles |
| 01/01/2007 |
Inflammatory and anti-inflammatory regulators alter levels of an inhibitor of apoptosis, survivin, in T-24 bladder cancer cells. J Urol 2007, 177:254 |
|
Journal Articles |
| 01/01/2007 |
Growth arrest and apoptosis of T-24 bladder cancer cells resulting from the HDAC inhibitor PXD101. Canadian Urological Association Journal 2007, 1(2),203. |
|
Journal Articles |
| 01/01/2007 |
. Effects of the new histone deacetylase inhibitor PXD101 in bladder cancer. Yale University Press,Yale J Biol Med. 2007 80(1). |
|
Book Chapters |
| 01/01/2003 |
A novel silicon gamma-aryl effect. Middletown, CT. Wesleyan University Press, 2003 |
|
Book Chapters |